Sofinnova Partners closes oversubscribed Fund XI at €650m
The European early-stage life sciences investor’s flagship fund will focus on biotech and medtech start-ups across Europe and North America.
The European early-stage life sciences investor’s flagship fund will focus on biotech and medtech start-ups across Europe and North America.
Copyright PEI Media
Not for publication, email or dissemination
